Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Troels K Bergmann

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
European Journal of Hospital Pharmacy : Science and Practice|June 24, 2021
Drug-drug cross contamination in the Swisslog fully automated medication handling systemAnne Skyggedal, Flemming Nielsen, Troels K Bergmann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
No evidence for taxane/platinum pharmacogenetic markers: just lack of power?Werner Vach, Troels K Bergmann, Kim Brøsen
Basic & Clinical Pharmacology & Toxicology|June 23, 2018
Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studiesPernille Tveden-Nyborg, Troels K Bergmann, Jens Lykkesfeldt
Clinical Pharmacokinetics|June 15, 2017
Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature ReviewTore B Stage, Troels K Bergmann, Deanna L Kroetz
Drugs in R&D|February 24, 2017
The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant RecipientsMads Juul Madsen, Troels K Bergmann, Kim Brøsen, et al.
Acta Oncologica (Stockholm, Sweden)|November 11, 2014
Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancerLise Eckhoff, Søren Feddersen, Ann S Knoop, et al.
Basic & Clinical Pharmacology & Toxicology|February 13, 2019
Response to Letter to the Editor concerning "Progression-free survival (PFS) in oncology: Caveat emptor!"Troels K Bergmann, Mette Marie H Christensen, Maija Bruun Haastrup, et al.
Basic & Clinical Pharmacology & Toxicology|December 3, 2025
BCPT 2026 Policy for Experimental and Clinical StudiesPernille Tveden-Nyborg, Troels K Bergmann, Niels Jessen, et al.
Clinical Pharmacokinetics|September 29, 2012
Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantationTroels K Bergmann, Katherine A Barraclough, Katie J Lee, et al.
Acta Oncologica (Stockholm, Sweden)|March 27, 2014
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysisChristina Therkildsen, Troels K Bergmann, Tine Henrichsen-Schnack, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
European Journal of Hospital Pharmacy : Science and Practice|June 24, 2021
Drug-drug cross contamination in the Swisslog fully automated medication handling systemAnne Skyggedal, Flemming Nielsen, Troels K Bergmann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
No evidence for taxane/platinum pharmacogenetic markers: just lack of power?Werner Vach, Troels K Bergmann, Kim Brøsen
Basic & Clinical Pharmacology & Toxicology|June 23, 2018
Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studiesPernille Tveden-Nyborg, Troels K Bergmann, Jens Lykkesfeldt
Clinical Pharmacokinetics|June 15, 2017
Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature ReviewTore B Stage, Troels K Bergmann, Deanna L Kroetz
Drugs in R&D|February 24, 2017
The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant RecipientsMads Juul Madsen, Troels K Bergmann, Kim Brøsen, et al.
Acta Oncologica (Stockholm, Sweden)|November 11, 2014
Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancerLise Eckhoff, Søren Feddersen, Ann S Knoop, et al.
Basic & Clinical Pharmacology & Toxicology|February 13, 2019
Response to Letter to the Editor concerning "Progression-free survival (PFS) in oncology: Caveat emptor!"Troels K Bergmann, Mette Marie H Christensen, Maija Bruun Haastrup, et al.
Basic & Clinical Pharmacology & Toxicology|December 3, 2025
BCPT 2026 Policy for Experimental and Clinical StudiesPernille Tveden-Nyborg, Troels K Bergmann, Niels Jessen, et al.
Clinical Pharmacokinetics|September 29, 2012
Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantationTroels K Bergmann, Katherine A Barraclough, Katie J Lee, et al.
Acta Oncologica (Stockholm, Sweden)|March 27, 2014
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysisChristina Therkildsen, Troels K Bergmann, Tine Henrichsen-Schnack, et al.
Pageof 4